SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-011911
Filing Date
2021-05-13
Accepted
2021-05-13 07:30:27
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20210331_10q.htm 10-Q 512101
2 EXHIBIT 10.3 ex_247948.htm EX-10.3 116451
3 EXHIBIT 31.1 ex_230485.htm EX-31.1 10862
4 EXHIBIT 31.2 ex_230486.htm EX-31.2 10946
5 EXHIBIT 32.1 ex_230487.htm EX-32.1 4523
6 EXHIBIT 32.2 ex_230488.htm EX-32.2 4531
  Complete submission text file 0001437749-21-011911.txt   3308405

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bcda-20210331.xml EX-101.INS 577671
8 XBRL TAXONOMY EXTENSION SCHEMA bcda-20210331.xsd EX-101.SCH 44681
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20210331_cal.xml EX-101.CAL 29144
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20210331_def.xml EX-101.DEF 253883
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20210331_lab.xml EX-101.LAB 240810
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20210331_pre.xml EX-101.PRE 280538
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 21917199
SIC: 2836 Biological Products, (No Diagnostic Substances)